Yeah,good luck with that,Marty...If there's anything that Al can do to help you,I'm sure he'd be delighted.

"The company is getting ready to start a clinical trial of its most advanced drug, code-named RE-021, in the first quarter of 2013. Shkreli is optimistic, based on conversations with the Food and Drug Administration, that this single study might be enough to obtain accelerated approval for the medicine in the U.S."

http://www.forbes.com/sites/matthewherper/2012/12/18/30-under-30-hedge-fund-gadfly-turns-biotech-entrepreneur/